Cargando…

Incidence, risk factors and mortality of tuberculosis in Danish HIV patients 1995-2007

BACKGROUND: Human Immunodeficiency Virus (HIV) infection predisposes to tuberculosis (TB). We described incidence, risk factors and prognosis of TB in HIV-1 infected patients during pre (1995-1996), early (1997-1999), and late Highly Active Antiretroviral Therapy (HAART) (2000-2007) periods. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Taarnhøj, Gry A, Engsig, Frederik N, Ravn, Pernille, Johansen, Isik S, Larsen, Carsten S, Røge, Birgit, Andersen, Aase B, Obel, Niels
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3115926/
https://www.ncbi.nlm.nih.gov/pubmed/21605366
http://dx.doi.org/10.1186/1471-2466-11-26
_version_ 1782206196615217152
author Taarnhøj, Gry A
Engsig, Frederik N
Ravn, Pernille
Johansen, Isik S
Larsen, Carsten S
Røge, Birgit
Andersen, Aase B
Obel, Niels
author_facet Taarnhøj, Gry A
Engsig, Frederik N
Ravn, Pernille
Johansen, Isik S
Larsen, Carsten S
Røge, Birgit
Andersen, Aase B
Obel, Niels
author_sort Taarnhøj, Gry A
collection PubMed
description BACKGROUND: Human Immunodeficiency Virus (HIV) infection predisposes to tuberculosis (TB). We described incidence, risk factors and prognosis of TB in HIV-1 infected patients during pre (1995-1996), early (1997-1999), and late Highly Active Antiretroviral Therapy (HAART) (2000-2007) periods. METHODS: We included patients from a population-based, multicenter, nationwide cohort. We calculated incidence rates (IRs) and mortality rates (MRs). Cox's regression analysis was used to estimate risk factors for TB infection with HAART initiation included as time updated variable. Kaplan-Meier was used to estimate mortality after TB. RESULTS: Among 2,668 patients identified, 120 patients developed TB during the follow-up period. The overall IR was 8.2 cases of TB/1,000 person-years of follow-up (PYR). IRs decreased during the pre-, early and late-HAART periods (37.1/1000 PYR, 12.9/1000 PYR and 6.5/1000 PYR respectively). African and Asian origin, low CD4 cell count and heterosexual and injection drug user route of HIV transmission were risk factors for TB and start of HAART reduced the risk substantially. The overall MR in TB patients was 34.4 deaths per 1,000 PYR (95% Confidence Interval: 22.0-54.0) and was highest in the first two years after the diagnosis of TB. CONCLUSIONS: Incidence of TB still associated with conventional risk factors as country of birth, low CD4 count and route of HIV infection while HAART reduces the risk substantially. The mortality in this patient population is high in the first two years after TB diagnosis.
format Online
Article
Text
id pubmed-3115926
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31159262011-06-16 Incidence, risk factors and mortality of tuberculosis in Danish HIV patients 1995-2007 Taarnhøj, Gry A Engsig, Frederik N Ravn, Pernille Johansen, Isik S Larsen, Carsten S Røge, Birgit Andersen, Aase B Obel, Niels BMC Pulm Med Research Article BACKGROUND: Human Immunodeficiency Virus (HIV) infection predisposes to tuberculosis (TB). We described incidence, risk factors and prognosis of TB in HIV-1 infected patients during pre (1995-1996), early (1997-1999), and late Highly Active Antiretroviral Therapy (HAART) (2000-2007) periods. METHODS: We included patients from a population-based, multicenter, nationwide cohort. We calculated incidence rates (IRs) and mortality rates (MRs). Cox's regression analysis was used to estimate risk factors for TB infection with HAART initiation included as time updated variable. Kaplan-Meier was used to estimate mortality after TB. RESULTS: Among 2,668 patients identified, 120 patients developed TB during the follow-up period. The overall IR was 8.2 cases of TB/1,000 person-years of follow-up (PYR). IRs decreased during the pre-, early and late-HAART periods (37.1/1000 PYR, 12.9/1000 PYR and 6.5/1000 PYR respectively). African and Asian origin, low CD4 cell count and heterosexual and injection drug user route of HIV transmission were risk factors for TB and start of HAART reduced the risk substantially. The overall MR in TB patients was 34.4 deaths per 1,000 PYR (95% Confidence Interval: 22.0-54.0) and was highest in the first two years after the diagnosis of TB. CONCLUSIONS: Incidence of TB still associated with conventional risk factors as country of birth, low CD4 count and route of HIV infection while HAART reduces the risk substantially. The mortality in this patient population is high in the first two years after TB diagnosis. BioMed Central 2011-05-23 /pmc/articles/PMC3115926/ /pubmed/21605366 http://dx.doi.org/10.1186/1471-2466-11-26 Text en Copyright ©2011 Taarnhøj et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Taarnhøj, Gry A
Engsig, Frederik N
Ravn, Pernille
Johansen, Isik S
Larsen, Carsten S
Røge, Birgit
Andersen, Aase B
Obel, Niels
Incidence, risk factors and mortality of tuberculosis in Danish HIV patients 1995-2007
title Incidence, risk factors and mortality of tuberculosis in Danish HIV patients 1995-2007
title_full Incidence, risk factors and mortality of tuberculosis in Danish HIV patients 1995-2007
title_fullStr Incidence, risk factors and mortality of tuberculosis in Danish HIV patients 1995-2007
title_full_unstemmed Incidence, risk factors and mortality of tuberculosis in Danish HIV patients 1995-2007
title_short Incidence, risk factors and mortality of tuberculosis in Danish HIV patients 1995-2007
title_sort incidence, risk factors and mortality of tuberculosis in danish hiv patients 1995-2007
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3115926/
https://www.ncbi.nlm.nih.gov/pubmed/21605366
http://dx.doi.org/10.1186/1471-2466-11-26
work_keys_str_mv AT taarnhøjgrya incidenceriskfactorsandmortalityoftuberculosisindanishhivpatients19952007
AT engsigfrederikn incidenceriskfactorsandmortalityoftuberculosisindanishhivpatients19952007
AT ravnpernille incidenceriskfactorsandmortalityoftuberculosisindanishhivpatients19952007
AT johansenisiks incidenceriskfactorsandmortalityoftuberculosisindanishhivpatients19952007
AT larsencarstens incidenceriskfactorsandmortalityoftuberculosisindanishhivpatients19952007
AT røgebirgit incidenceriskfactorsandmortalityoftuberculosisindanishhivpatients19952007
AT andersenaaseb incidenceriskfactorsandmortalityoftuberculosisindanishhivpatients19952007
AT obelniels incidenceriskfactorsandmortalityoftuberculosisindanishhivpatients19952007